"Public Perception of Weight-Loss Drugs and Obesity in the U.S."

A Pew Research Center survey of 10,133 U.S. adults reveals that about three-quarters of Americans are familiar with weight-loss drugs like Ozempic and Wegovy, with 53% considering them good options for people with obesity or weight-related health conditions. However, only 16% believe these drugs will have a significant impact on reducing obesity in the U.S. The survey also shows that most Americans do not believe willpower alone is enough for weight loss, with diet, exercise, stress, and genetics being identified as key factors impacting weight. The study highlights the ongoing societal discussion about weight and the factors influencing it, with modest differences in views across demographic groups.